Cite
HARVARD Citation
Atalay, S. et al. (2022). Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial. Journal of dermatological treatment. pp. 2680-2684. [Online].